Products
Platform
Research
Market
Learn
Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.31 | 1.87 |
NAV | ₹31.00 | ₹40.36 |
Fund Started | 20 Jun 2019 | 25 Jun 2018 |
Fund Size | ₹829.63 Cr | ₹6226.82 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.31
1.87
NAV
₹31.00
₹40.36
Fund Started
20 Jun 2019
25 Jun 2018
Fund Size
₹829.63 Cr
₹6226.82 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | -1.43% | 4.56% |
3 Year | 20.63% | 27.00% |
5 Year | 16.17% | 20.85% |
1 Year
-1.43%
4.56%
3 Year
20.63%
27.00%
5 Year
16.17%
20.85%
Holding Analysis
Equity | 98.34% | 97.55% |
Cash | 1.66% | 2.45% |
Equity
98.34%
97.55%
Cash
1.66%
2.45%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.17% |
Apollo Hospitals Enterprise Ltd. | 7.59% |
Cipla Ltd. | 6.83% |
Fortis Healthcare Ltd. | 5.58% |
Abbott India Ltd. | 4.57% |
Lupin Ltd. | 4.52% |
Torrent Pharmaceuticals Ltd. | 4.45% |
Ajanta Pharma Ltd. | 3.75% |
Ipca Laboratories Ltd. | 3.55% |
Anthem Biosciences Ltd. | 3.22% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.58% |
Dr. Reddy's Laboratories Ltd. | 9.10% |
Divi's Laboratories Ltd. | 8.75% |
Aurobindo Pharma Ltd. | 8.25% |
Cipla Ltd. | 6.92% |
Lupin Ltd. | 5.43% |
Alkem Laboratories Ltd. | 4.05% |
Biocon Ltd. | 3.11% |
Gland Pharma Ltd. | 2.97% |
Mankind Pharma Ltd. | 2.95% |
Fund Manager
Name | Dhaval Joshi | Dharmesh Kakkad |
Start Date | 10 Jun 2024 | 23 Feb 2021 |
Name
Dhaval Joshi
Dharmesh Kakkad
Start Date
10 Jun 2024
23 Feb 2021
About Fund
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 20 Jun 2019 | 25 Jun 2018 |
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Jun 2019
25 Jun 2018